What you carry at this position in your DNA and what research says about it.
Nicotine Addiction Risk: 6/10 evidence, 15 publications.
You're viewing every possible genotype for this variant.
None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.
Sample genotype (not yours): G/G
Higher Risk of Nicotine Dependence
Nicotine addiction risk and smoking intensity are higher with this genotype. The brain's reward system may show heightened sensitivity to nicotine, making tobacco use more reinforcing.
What this genotype means: Higher risk of nicotine dependence; Likely to smoke more heavily; Increased risk of smoking-related health issues.
Sample genotype (not yours): A/A
Lowest Risk of Nicotine Dependence
Nicotine addiction risk is lowest with two copies of the protective allele. This genotype is strongly linked to lighter smoking habits and a lower likelihood of developing dependence.
What this genotype means: Significantly lower risk of nicotine dependence; Lighter smoking habits; Reduced risk of smoking-related diseases.
Sample genotype (not yours): G/A
Lower Risk of Nicotine Dependence
Nicotine addiction risk is reduced due to the presence of one protective allele. This genotype is associated with lighter smoking habits and a lower likelihood of severe dependence.
What this genotype means: Lower risk of nicotine dependence; Less likely to engage in heavy smoking; Lower risk of smoking-related complications.
Gene function and biological role
Gene Function: The CHRNA3 gene encodes the alpha 3 subunit of the nicotinic acetylcholine receptor, which is a key component of the brain's cholinergic system. This receptor is highly expressed in areas of the brain involved in reward pathways and autonomic function. Genetic variations in the CHRNA5-CHRNA3-CHRNB4 gene cluster on chromosome 15 are strongly linked to smoking behaviors and nicotine dependence. These receptors bind nicotine, modulating the release of dopamine and other neurotransmitters that reinforce addictive behaviors. Alterations in receptor expression or function can significantly influence how a person experiences nicotine and their susceptibility to heavy smoking.
Variant Impact: The rs578776 variant is located in the 3' untranslated region of the CHRNA3 gene, a region critical for regulating gene expression and mRNA stability. This single nucleotide polymorphism involves a change from a guanine to an adenine allele. The alteration is thought to modify the regulatory sequence of the CHRNA3 gene, thereby affecting the density or sensitivity of nicotinic receptors in the brain. This molecular change directly impacts how the brain's reward system responds to nicotine exposure, influencing both the development of dependence and the ease of quitting.
Key Insight: The minor A allele of this variant acts as a protective shield, significantly reducing the likelihood of developing severe nicotine dependence. Individuals with the G/G genotype may experience heightened brain reward activation in response to nicotine, making smoking more reinforcing and harder to quit.
Location: CHRNA3. Chromosome 15 · 15q25.1 · 78.6 Mb
Estimated prevalence by population
Global 38.1%; European 52.7%; African 21.3%; East Asian 4.6%; South Asian 28.2%; Americas 22.4%; Ashkenazi 53.8%; Finnish 46.1%; Middle Eastern 39.2%; Amish 69.1%.
Estimated GG genotype frequency.
Global 43.9%; European 39.8%; African 49.7%; East Asian 33.7%; South Asian 49.8%; Americas 49.9%; Ashkenazi 39.1%; Finnish 43.6%; Middle Eastern 46.8%; Amish 28.1%.
Estimated GA genotype frequency.
Global 18.0%; European 7.5%; African 29.0%; East Asian 61.7%; South Asian 22.0%; Americas 27.7%; Ashkenazi 7.1%; Finnish 10.3%; Middle Eastern 14.0%; Amish 2.9%.
Estimated AA genotype frequency.
Showing effects for G/G genotype
Neurology & Mental Health
Addiction & Reward
Nicotine Dependence. Evidence: 6/10. Source: PMID 19706762. Increased Risk.
Smoking Intensity. Evidence: 3/10. Source: PMID 21810735. Heavier Smoking.
Smoking Cessation. Evidence: 6/10. Source: PMID 31402126. Increased Likelihood.
Showing effects for A/A genotype
Nicotine Dependence. Evidence: 6/10. Source: PMID 19706762. Lower Risk.
Smoking Intensity. Evidence: 3/10. Source: PMID 21810735. Lighter Smoking.
Smoking Cessation. Evidence: 6/10. Source: PMID 31402126. Typical.
Showing effects for G/A genotype
What this genotype means for the people who carry it
Sample genotype: GG (Homozygous)
Nicotine dependence risk is significantly higher in those who inherit two copies of the G allele. Research indicates that this genetic profile is linked to increased activation in the brain's reward pathways during nicotine exposure, making tobacco use more reinforcing. Consequently, G/G carriers are more likely to engage in heavier smoking, consuming more cigarettes per day to satisfy cravings. This increased consumption indirectly elevates the long-term risk of smoking-related health complications, such as lung cancer. However, some clinical studies suggest that if G/G carriers do attempt to quit, they may have a relatively higher likelihood of successful smoking cessation compared to other genotypes under certain treatment conditions.
Higher risk of nicotine dependence; Likely to smoke more heavily; Increased risk of smoking-related health issues.
Sample genotype: AA (Homozygous)
Nicotine dependence risk is lowest in those who inherit two copies of the protective A allele. This genotype is associated with a significantly lower likelihood of developing a severe addiction to nicotine. Research shows that A/A carriers tend to smoke fewer cigarettes per day and are less likely to become heavy smokers. By reducing the intensity and duration of smoking, this genotype indirectly lowers the risk of developing lung cancer and other tobacco-related illnesses. Furthermore, individuals with this genetic profile often find it easier to quit smoking if they do start, as they experience fewer withdrawal symptoms and lower cravings.
Significantly lower risk of nicotine dependence; Lighter smoking habits; Reduced risk of smoking-related diseases.
Sample genotype: GA (Heterozygous)
Nicotine dependence risk is reduced in those who carry one copy of the protective A allele. This genetic variation is thought to alter the expression of nicotinic receptors in the brain, leading to a more balanced response to nicotine stimulation. As a result, G/A carriers are less likely to develop severe nicotine addiction or engage in heavy, high-volume smoking. This protective effect also translates to a lower risk of developing smoking-related conditions like lung cancer over time. Additionally, some studies suggest that carriers of the protective A allele experience less difficulty when attempting to quit smoking.
Lower risk of nicotine dependence; Less likely to engage in heavy smoking; Lower risk of smoking-related complications.
Variants with shared genetic architecture
rs1051730 · CHRNA3 Gene · Chr 15 · Nicotine and Lung Risk
rs8040868 · CHRNA3 Gene · Chr 15 · Lung Health and Smoking Risk
rs12914385 · CHRNA3 Gene · Chr 15 · Lung and Respiratory Health
Content updated August 2026.
ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.
Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026
Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com